0.7910
+0.0515
+(6.96%)
At close: 4:00:00 PM EDT
0.7910
0.00
(0.00%)
After hours: 4:05:07 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.14 | -0.14 | -0.57 | -0.72 |
| Low Estimate | -0.14 | -0.14 | -0.58 | -0.84 |
| High Estimate | -0.13 | -0.13 | -0.55 | -0.61 |
| Year Ago EPS | -0.15 | -0.14 | -0.56 | -0.57 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | -- | -- | -- | 2.94M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 7.1M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.17 | -0.17 | -0.16 |
| EPS Actual | -0.15 | -0.14 | -0.13 | -0.14 |
| Difference | 0.01 | 0.02 | 0.04 | 0.02 |
| Surprise % | 4.26% | 15.15% | 23.53% | 14.28% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.14 | -0.14 | -0.57 | -0.72 |
| 7 Days Ago | -0.14 | -0.14 | -0.57 | -0.71 |
| 30 Days Ago | -0.14 | -0.14 | -0.57 | -0.61 |
| 60 Days Ago | -0.18 | -0.18 | -0.74 | -0.63 |
| 90 Days Ago | -0.18 | -0.18 | -0.74 | -0.63 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 3 | 3 | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NAUT | 8.89% | 2.38% | -1.19% | -26.47% |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Downgrade | Goldman Sachs: Neutral to Sell | 12/5/2024 |
| Initiated | Guggenheim: Buy | 6/27/2024 |
| Reiterates | Morgan Stanley: Equal-Weight to Equal-Weight | 8/3/2023 |
| Maintains | Morgan Stanley: Equal-Weight | 8/3/2022 |
| Maintains | Goldman Sachs: Neutral | 8/3/2022 |
| Maintains | Goldman Sachs: Neutral | 7/14/2022 |
Related Tickers
SEER Seer, Inc.
2.0000
-3.38%
LYRA Lyra Therapeutics, Inc.
0.1022
+20.38%
GBIO Generation Bio Co.
0.3873
+10.97%
AVTE Aerovate Therapeutics, Inc.
2.6600
+3.10%
IMTX Immatics N.V.
4.1400
+4.28%
STTK Shattuck Labs, Inc.
0.9499
+4.81%
PRLD Prelude Therapeutics Incorporated
0.7082
+10.35%
VRCA Verrica Pharmaceuticals Inc.
0.4840
+9.35%
PROK ProKidney Corp.
0.7313
+19.20%
PASG Passage Bio, Inc.
0.3625
+0.17%